Topics

Glioblastoma | Treatment | Immunotherapy | Cell therapy

Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Cell therapy

Nabors LB, Lamb LS, Goswami T, Rochlin K, Youngblood SL.
Adoptive cell therapy for high grade gliomas using simultaneous temozolomide and intracranial mgmt-modified γδ t cells following standard post-resection chemotherapy and radiotherapy: current strategy and future directions.
Front Immunol. 2024 Feb 7;15:1299044. doi: 10.3389/fimmu.2024.1299044. PMID: 38384458. Interventional study; Perspective. ˍ

Wong ET, Cielo D, Svokos K, Doberstein C, Sampath P, Donahue JE, Punsoni M, Rodrigues N, Rothell F, Edwards R, Wang E, Riccelli T, Chuck C, Shaaya EA, Sastry R, Ali R, Shao B, Abdulrazeq H, Sun FW, Feler J, Santos Fontánez SE, Nieves NA, Dobertsein C, Dailey J, Yu C, Sarangi S, Elinzano H, Boxerman JL, Yu E, Safran H, Seyhan AA, El-Deiry WS, Keith S, Gokaslan ZL, Chen CC, Malik A.
IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge.
Front Oncol. 2025 Mar 18;15:1556450. doi: 10.3389/fonc.2025.1556450. PMID: 40171253. Interventional study protocol. ˍ